GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Lu X, Williams Z, Hards K, Tang J, Cheung CY, Aung HL, Wang B, Liu Z, Hu X, Lenaerts A et al.. (2019)
Pyrazolo[1,5- a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis. ACS Infect Dis, 5 (2): 239-249. [PMID:30485737] |
|
2. Tang J, Wang B, Wu T, Wan J, Tu Z, Njire M, Wan B, Franzblauc SG, Zhang T, Lu X et al.. (2015)
Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents. ACS Med Chem Lett, 6 (7): 814-8. [PMID:26191372] |
|
3. Yu W, Chiwala G, Gao Y, Liu Z, Sapkota S, Lu Z, Guo L, Khan SA, Zhong N, Zhang T. (2020)
TB47 and clofazimine form a highly synergistic sterilizing block in a second-line regimen for tuberculosis in mice. Biomed Pharmacother, 131: 110782. [PMID:33152940] |
|
4. Yu W, Yusuf B, Wang S, Tian X, Hameed HMA, Lu Z, Chiwala G, Alam MS, Cook GM, Maslov DA et al.. (2021)
Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine, and Linezolid in a Murine Model of Tuberculosis. Antimicrob Agents Chemother, 65 (10): e0070621. [PMID:34280022] |
|
5. Zhou S, Wang W, Zhou X, Zhang Y, Lai Y, Tang Y, Xu J, Li D, Lin J, Yang X et al.. (2021)
Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates. Elife, 10. [PMID:34819223] |